Literature DB >> 8021377

Margin control for lentigo maligna.

J K Robinson1.   

Abstract

BACKGROUND: Lentigo maligna is an in situ malignant melanoma for which the treatment of choice is surgical excision. The current recommendation is local resection with a 0.5 to 1.0 cm margin of normal skin. Because many lesions occur on the face, the narrowest possible margin reduces the amount of scarring. Controversy surrounds the use of Mohs micrographic surgery to preserve normal skin and resect the lentigo maligna.
OBJECTIVE: The purposes of this prospective study were to determine the narrowest possible margin of resection of lentigo maligna and the accuracy of frozen and fixed histologic specimens from those margins. In addition, the benefit of adjunctive immunoperoxidase staining with antibodies to S-100 protein and HMB-45 monoclonal antibody was examined retrospectively.
METHODS: A Wood's light was used to delineate the clinical margin in 16 cases of lentigo maligna that were resected with serial excisions 0.3, 0.6, 1.0, and 1.3 cm from the clinical border of the tumor. Frozen sections were confirmed by fixed histopathologic specimens. Subsequently these tissue blocks were examined with antibodies to S-100 protein and HMB-45 monoclonal antibodies. Patients were observed 5 to 9 years.
RESULTS: One of the 16 patients had a recurrence 8 years after surgery. Although lesions with a diameter less than 2.0 cm had narrower margins of resection, the majority of lesions were resected with a margin of 0.6 to 1.0 cm. Lesions larger than 3.0 cm in diameter required a margin of resection greater than 1.0 cm. The antibody to S-100 protein was neither sensitive nor specific enough to assist with identification of the process. HMB-45 monoclonal antibody was sensitive and assisted in the identification of atypical melanocytes.
CONCLUSION: The modifications of Mohs micrographic surgery including the use of fixed histopathologic specimens and the use of HMB-45 monoclonal antibody to help delineate atypical melanocytes offer the possibility of narrower margins of resection for lentigo maligna.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8021377     DOI: 10.1016/s0190-9622(94)70140-7

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  10 in total

1.  Immunohistochemistry in mohs micrographic surgery: a review of the literature.

Authors:  Novie Sroa; Shannon Campbell; Larisa Ravitskiy
Journal:  J Clin Aesthet Dermatol       Date:  2009-07

2.  Dermacase. Malignant lentigo.

Authors:  T Enta
Journal:  Can Fam Physician       Date:  1995-02       Impact factor: 3.275

3.  Outcomes of Melanoma In Situ Treated With Mohs Micrographic Surgery Compared With Wide Local Excision.

Authors:  Adi Nosrati; Jacqueline G Berliner; Shilpa Goel; Joseph McGuire; Vera Morhenn; Juliana R de Souza; Yildiray Yeniay; Rasnik Singh; Kristina Lee; Mio Nakamura; Rachel R Wu; Ann Griffin; Barbara Grimes; Eleni Linos; Mary Margaret Chren; Roy Grekin; Maria L Wei
Journal:  JAMA Dermatol       Date:  2017-05-01       Impact factor: 10.282

4.  Staged Excision for Lentigo Maligna and Lentigo Maligna Melanoma: Analysis of Surgical Margins and Long-term Recurrence in 68 Cases from a Single Practice.

Authors:  Joshua B Wilson; Hobart W Walling; Richard K Scupham; Andrew K Bean; Roger I Ceilley; Kirsten E Goetz
Journal:  J Clin Aesthet Dermatol       Date:  2016-06-01

Review 5.  Revealing The Unseen: A Review of Wood's Lamp in Dermatology.

Authors:  Joseph M Dyer; Valerie M Foy
Journal:  J Clin Aesthet Dermatol       Date:  2022-06

Review 6.  Skin cancer. Recognition and treatment.

Authors:  R Marks; R J Motley
Journal:  Drugs       Date:  1995-07       Impact factor: 9.546

Review 7.  Diagnosis and management of lentigo maligna: a review.

Authors:  Julia M Kasprzak; Yaohui G Xu
Journal:  Drugs Context       Date:  2015-05-29

8.  Pharmacological inhibitors of c-KIT block mutant c-KIT mediated migration of melanocytes and melanoma cells in vitro and in vivo.

Authors:  Christian Posch; Homayoun Moslehi; Martina Sanlorenzo; Gary Green; Igor Vujic; Renate Panzer-Grümayer; Klemens Rappersberger; Susana Ortiz-Urda
Journal:  Oncotarget       Date:  2016-07-19

9.  Histological Peripheral Margins and Recurrence of Melanoma In Situ Treated with Wide Local Excision.

Authors:  Francisco S Moura; Lucy E Homer; Stuart W McKirdy
Journal:  J Skin Cancer       Date:  2020-10-29

Review 10.  Melanoma In Situ: A Critical Review and Re-Evaluation of Current Excision Margin Recommendations.

Authors:  Erica B Friedman; Richard A Scolyer; Gabrielle J Williams; John F Thompson
Journal:  Adv Ther       Date:  2021-05-28       Impact factor: 3.845

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.